NYSDA Publications

AHRQ Issues Regulatory Update

Mar 11, 2025

The Agency for Healthcare Research and Quality (AHRQ) has issued its weekly regulatory update, which can be read below.

AHRQ News Now banner updated 2023

March 11, 2025, Issue #949

 

AHRQ Stats: Trends in MRSA Rates, 2016 to 2021

While the overall rate of adult inpatient stays with a diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA) decreased by nearly 11 percent between 2016 and 2021, rates of MRSA infections that occurred after admission increased by 47 percent between 2019 and 2021. (Source: AHRQ Healthcare Cost and Utilization Project Statistical Brief #315, Overview of Methicillin-Resistant Staphylococcus aureus (MRSA)-Related Inpatient Stays, 2016-2021.)

Today's Headlines:

New Interactive Data Resource Illustrates Trends in Sepsis Hospital Care

A new interactive tool from AHRQ allows researchers, policymakers and others to explore trends in hospital care for sepsis, a life-threatening condition that is among the most expensive to treat in U.S. hospitals. Sepsis caseloads in inpatient settings at nonfederal acute care hospitals increased from 1.8 million in 2016 to 2.5 million in 2021, an increase of nearly 40 percent. AHRQ’s new resource, released during Patient Safety Awareness Week 2025 and based on AHRQ’s Healthcare Cost and Utilization Project data, allows for the analysis of sepsis-related data over time in two important areas:
  • Morbidity and in-hospital mortality, including inpatient stays and emergency department utilization, readmissions, post-acute care transitions after hospitalization and in-hospital deaths.
  • Outcomes of sepsis hospitalizations, including length of stay, average hospital cost and total hospital costs by patient characteristics.
Additional data depicting state-specific utilization in sepsis hospital care will be added soon to the data visualization. Access this new data resource and other AHRQ data visualizations for information on diverse topics such as trends in ownership of healthcare practices, opioid hospitalizations and traumatic brain injuries.

AHRQ Celebrates Patient Safety Awareness Week

During Patient Safety Awareness Week 2025, AHRQ is showcasing its role as the federal agency leading support for research and initiatives to protect patients from avoidable harms. Highlights include—
Access more about AHRQ’s efforts to advance the field of patient safety, including information about diagnostic safety, safety research summaries, resources by setting, quality measures and more.

Delaying Broad-Spectrum Antibiotics Does Not Result in Worse Outcomes

Delaying delivery of broad-spectrum antibiotics does not result in worse patient outcomes, according to an AHRQ-supported article in Clinical Infectious Diseases. In a study that compared 67,046 patients who received delayed broad-spectrum therapy with 67,046 patients who received early broad-spectrum therapy, the authors found that death occurred in 8.7 percent of delayed broad-spectrum treatment cases, adverse drug events in 8.4 percent and readmission in 10.5 percent. In contrast, after early treatment, death occurred in 9.5 percent of cases, adverse drug events in 7.2 percent and readmission in 11.8 percent. These findings demonstrated that beginning therapy with narrower-spectrum antibiotics may not pose significant risks and could reduce antibiotic overexposure. Access the abstract.

Highlights From AHRQ’s Patient Safety Network

AHRQ’s Patient Safety Network (PSNet) highlights journal articles, books and tools related to patient safety. Articles featured this week include—

Review additional new publications in PSNet’s current issue, including recent cases and commentaries and AHRQ’s WebM&M (Morbidity and Mortality Rounds on the Web).

Upcoming AHRQ Webinars

New Research and Evidence From AHRQ

AHRQ in the Professional Literature

Outpatient low-dose initiation of buprenorphine for people using fentanyl. Suen LW, Chiang AY, Jones BLH, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2456253. Access the abstract on PubMed®.

A perspective on the use of patient-reported experience and patient-reported outcome measures in ambulatory healthcare. Hays RD, Quigley DD. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan 17. [Epub ahead of print.] Access the abstract on PubMed®.

Reducing antibiotic duration for acute otitis media: clinician, administrator, and parental insights to inform implementation of system-level interventions. Rinehart DJ, Gilbert A, O'Leary S, et al. Antimicrob Steward Healthc Epidemiol. 2025 Jan 2025;5(1):e3. Access the abstract on PubMed®.

Access to pediatric bed capacity according to social determinants of health: all beds are not created equal. Hegland TA, Day RT, Moynihan KM. J Pediatr. 2025 Mar;278:114447. Epub 2024 Dec 21. Access the abstract on PubMed®.

Hospitalization patterns for rural-residing children from 2002 to 2017. McDaniel CE, Hall M, Berry JG. Acad Pediatr. 2025 Jan-Feb;25(1):102554. Epub 2024 Aug 5. Access the abstract on PubMed®.

CT pulmonary angiogram clinical pretest probability tool: impact on emergency department utilization. Rosovsky RP, Isabelle M, Abbasi N, et al. J Am Coll Radiol. 2024 Dec;21(12):1851-61. Epub 2024 Aug 10. Access the abstract on PubMed®.

Hospital-physician integration and cardiac rehabilitation following major cardiovascular events. Thai NH, Post B, Young G, et al. JAMA Netw Open. 2025 Mar 3;8(3):e2462580. Access the abstract on PubMed®.

Trends in Medicaid take-up among eligible adults after the Affordable Care Act Medicaid Expansions: 2014-2019. Abdus S. Med Care Res Rev. 2025 Feb;82(1):100-6. Epub 2024 Sep 5. Access the abstract on PubMed®.

Contact Information
For comments or questions about AHRQ News Now, contact Bruce Seeman, (301) 427-1998 or Bruce.Seeman@ahrq.hhs.gov.